• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FARMA-DERMA S.R.L. REVAREE VAGINAL SUPPOSITORY; LUBRICANT, PERSONAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FARMA-DERMA S.R.L. REVAREE VAGINAL SUPPOSITORY; LUBRICANT, PERSONAL Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Fever (1858); Urinary Tract Infection (2120); Kidney Infection (4502)
Event Date 11/24/2022
Event Type  Injury  
Event Description
A 59-year-old female reported that she received treatment for 10 hrs in emergency room after developing "an infection, a urinary tract infection, a kidney infection and near-sepsis", 4 days after restarting the vaginal suppository product revaree.She had taken the product for a few months without incident, stopped and then restarted.Four days after restarting, she developed worsening pelvic discomfort and fever of 103.5 f.She went to the emergency room, when she was diagnosed with a uti, kidney infection and vaginal infection.She had a negative ct scan and ultrasound and had bloodwork performed.She received "2 bags of iv fluids" and a dose of iv antibiotics.She was told that she had "near sepsis' and if she has waited longer.Her described the event, or problem condition may have worsened.Although she had taken the product for 2 months, with some improvement, she has decided to permanently discontinue the product.She was sent home with a prescription for 2 weeks of doxycycline.Discussion: because the consumer was on the product at the time of the event.It is impossible to rule out a possible contribution.Utls, typically non-serious, have been reported in women taking the product.In some women.The product may be irritative, especially in the setting of atrophic vaginal tissue associated with menopause.Although the customer was not hospitalized.The intensity of therapy and mention that she was "near sepsis" elevates this case to an important medical event.In addition, she noted that the hospital was reported to be full.The manufacturer will continue to carefully monitor the safety of its products.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REVAREE VAGINAL SUPPOSITORY
Type of Device
LUBRICANT, PERSONAL
Manufacturer (Section D)
FARMA-DERMA S.R.L.
MDR Report Key16157370
MDR Text Key307488004
Report NumberMW5114312
Device Sequence Number1
Product Code NUC
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Physician
Type of Report Initial
Report Date 01/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/12/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Is the Reporter a Health Professional? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
DOXYCYCLINE; IV ANTIBIOTICS; IV FLUIDS
Patient Outcome(s) Required Intervention; Other;
Patient Age59 YR
Patient SexFemale
Patient Weight73 KG
-
-